Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $51.5M
Liabilities Breakdown FY2019
Total Liabilities: $29.8M
Asset Breakdown
Total Assets: $51.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.3M | 4.5% |
| Accounts Receivable | $10.3M | 20.1% |
| Inventory | $1.8M | 3.5% |
| Property, Plant & Equipment | $6.8M | 13.2% |
| Goodwill | $8.4M | 16.4% |
| Intangible Assets | $15.8M | 30.8% |
| Other Assets | $6.0M | 11.6% |
Liabilities Breakdown
Total Liabilities: $29.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.7M | 15.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.1M | 84.2% |